Proteomic analyses of CSF from patients with stable MCI versus MCI with AD identified the phosphorylated C-terminal thrombin cleavage fragment of OPN as a biomarker of MCI that progressed to AD [126]. This evidence concerns the gene SPP1 and Alzheimer disease.